A framework for multi-faceted content analysis of social media chatter regarding non-medical use of prescription medications

Author:

Raza Shaina,Schwartz Brian,Lakamana Sahithi,Ge Yao,Sarker Abeed

Abstract

Abstract Background Substance use, including the non-medical use of prescription medications, is a global health problem resulting in hundreds of thousands of overdose deaths and other health problems. Social media has emerged as a potent source of information for studying substance use-related behaviours and their consequences. Mining large-scale social media data on the topic requires the development of natural language processing (NLP) and machine learning frameworks customized for this problem. Our objective in this research is to develop a framework for conducting a content analysis of Twitter chatter about the non-medical use of a set of prescription medications. Methods We collected Twitter data for four medications—fentanyl and morphine (opioids), alprazolam (benzodiazepine), and Adderall® (stimulant), and identified posts that indicated non-medical use using an automatic machine learning classifier. In our NLP framework, we applied supervised named entity recognition (NER) to identify other substances mentioned, symptoms, and adverse events. We applied unsupervised topic modelling to identify latent topics associated with the chatter for each medication. Results The quantitative analysis demonstrated the performance of the proposed NER approach in identifying substance-related entities from data with a high degree of accuracy compared to the baseline methods. The performance evaluation of the topic modelling was also notable. The qualitative analysis revealed knowledge about the use, non-medical use, and side effects of these medications in individuals and communities. Conclusions NLP-based analyses of Twitter chatter associated with prescription medications belonging to different categories provide multi-faceted insights about their use and consequences. Our developed framework can be applied to chatter about other substances. Further research can validate the predictive value of this information on the prevention, assessment, and management of these disorders.

Funder

National Institute on Drug Abuse

Publisher

Springer Science and Business Media LLC

Reference84 articles.

1. Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Products - Vital Statistics Rapid Release - Provisional Drug Overdose Data. National Center for Health Statistics. 2022.

2. Hughes A, Williams MR, Lipari RN, Bose J, Copello EA, Kroutil LA. Prescription drug use and misuse in the United States: results from the 2015 national survey on drug use and health. NSDUH data review, substance abuse and mental health services administration. Natl Survey Drug Use Health. 2016;2016:1–41.

3. Singh J. Centers for disease control and prevention. Indian J Pharmacol. 2004;36:268–9. https://www.cdc.gov/. Accessed 27 Jan 2022.

4. U.S. Food and Drug Administration. Neurontin. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf. Accessed 22 July 2023.

5. Hochstein C, Goshorn J, Chang F. United states national library of medicine drug information portal. Med Ref Serv Q. 2009;28(2):154–63.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3